Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Frontiers in Physiology|May 1, 2018
Silencing of Chemosensory Protein Gene NlugCSP8 by RNAi Induces Declining Behavioral Responses of Nilaparvata lugensMuhammad I Waris, Aneela Younas, Muhammad T Ul Qamar, et al.Current Problems in Cardiology|March 15, 2021
Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort StudyIslam Eljilany, Mohamed Elarref, Nabil Shallik, et al.Genome Announcements|September 2, 2017
Complete Genome Sequence of Salmonella enterica Lytic Bacteriophage LPST10, Isolated in ChinaXingxing Dong, Chenxi Huang, Mohamed Khairy Morsy, et al.Pharmacogenetics and Genomics|April 7, 2022
Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantationZainab Omer Ali, Loulia Bader, Shaaban Mohammed, et al.Circulation. Cardiovascular Genetics|December 16, 2010
Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES)Yuxin Niu, Yan Gong, Taimour Y Langaee, et al.Clinical Pharmacology and Therapeutics|February 15, 2023
Warfarin-Rifampin-Gene (WARIF-G) Interaction: A Retrospective, Genetic, Case-Control StudyMuhammad Salem, Ahmed El-Bardissy, Mohamed Nabil Elshafei, et al.The Pharmacogenomics Journal|October 27, 2019
The effect of genetic and nongenetic factors on warfarin dose variability in Qatari populationLoulia Bader, Ahmad Mahfouz, Mohammed Kasem, et al.Frontiers in Immunology|November 14, 2025
Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study)Nabil E Omar, Shereen Elazzazy, Anas Hamad, et al.Frontiers in Immunology|July 6, 2026
Correction: Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study)Nabil E Omar, Shereen Elazzazy, Anas Hamad, et al.Clinical and Translational Science|June 11, 2024
Clinical versus fixed warfarin dosing and the impact on quality of anticoagulation (The ClinFix trial)Amr M Fahmi, Ahmed El Bardissy, Mohamed Omar Saad, et al.Pageof 8